21 CFR Part 211 - Current Good Manufacturing Practice
Subpart I - Laboratory Controls

21 CFR Part 211 - Current Good Manufacturing Practice CFR211-I-165: Section 211.165 - Testing and Release for Distribution

What does CFR211-I-165 require?

Each batch of drug product required to be free of objectionable microorganisms shall be tested and determined to be in compliance before release.

Maintained by Gerard BlokdykVerified against the published standard Control text last updated

Other controls in Subpart I - Laboratory Controls

Query this from an agent

The graph holds this control, the 0 it maps to, and the evidence behind each claim, over MCP and REST.

MCP endpointAll 21 CFR Part 211 - Current Good Manufacturing Practice controls